Cargando…

Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration

INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with limited therapeutic options and high lethality, related to alveolar type II epithelial (ATII) cell dysregulation, the abnormal repair of alveolar epithelial cells and activation of fibroblasts promote the develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Zhenli, Yin, Hang, Liu, Jiani, He, Ying, Song, Shengren, Peng, Xiaomin, Huang, Xihui, Lai, Yunxin, Li, Shuang, Luo, Qun, Su, Jin, Yang, Penghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632910/
https://www.ncbi.nlm.nih.gov/pubmed/37940355
http://dx.doi.org/10.1136/bmjresp-2022-001568
_version_ 1785132672046071808
author Fu, Zhenli
Yin, Hang
Liu, Jiani
He, Ying
Song, Shengren
Peng, Xiaomin
Huang, Xihui
Lai, Yunxin
Li, Shuang
Luo, Qun
Su, Jin
Yang, Penghui
author_facet Fu, Zhenli
Yin, Hang
Liu, Jiani
He, Ying
Song, Shengren
Peng, Xiaomin
Huang, Xihui
Lai, Yunxin
Li, Shuang
Luo, Qun
Su, Jin
Yang, Penghui
author_sort Fu, Zhenli
collection PubMed
description INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with limited therapeutic options and high lethality, related to alveolar type II epithelial (ATII) cell dysregulation, the abnormal repair of alveolar epithelial cells and activation of fibroblasts promote the development of pulmonary fibrosis. Fatty acid binding protein 1 (FABP1) was significantly downregulated in the fibrotic state by proteomics screening in our previous date, and the ATII cell dysregulation can be mediated by FABP1 via regulating fatty acid metabolism and intracellular transport. The aim of this study was to evaluate the role and potential mechanism of FABP1 in the development of pulmonary fibrosis. METHODS: Proteomics screening was used to detect changes of the protein profiles in two different types (induced by bleomycin and silica, respectively) of pulmonary fibrosis models. The localisation of FABP1 in mouse lung was detected by Immunofluorescence and immunohistochemistry. Experimental methods such as lung pathology, micro-CT, western blotting, small animal imaging in vivo, EdU, etc were used to verify the role of FABP1 in pulmonary fibrosis. RESULTS: The expression of FABP1 in the mouse lung was significantly reduced in the model of pulmonary fibrosis from our proteomic analysis and immunological methods, the double immunofluorescence staining showed that FABP1 was mainly localised in type II alveolar epithelial cells. Additionally, the expression of FABP1 was negatively correlated with the progression of pulmonary fibrosis. Further in vivo and in vitro experiments showed that overexpression of FABP1 alleviated pulmonary fibrosis by protecting alveolar epithelium from injury and promoting cell survival. CONCLUSION: Our findings provide a proof-of-principle that FABP1 may represent an effective treatment for pulmonary fibrosis by regulating alveolar epithelial regeneration, which may be associated with the fatty acid metabolism in ATII cells.
format Online
Article
Text
id pubmed-10632910
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-106329102023-11-10 Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration Fu, Zhenli Yin, Hang Liu, Jiani He, Ying Song, Shengren Peng, Xiaomin Huang, Xihui Lai, Yunxin Li, Shuang Luo, Qun Su, Jin Yang, Penghui BMJ Open Respir Res Interstitial Lung Disease INTRODUCTION: Idiopathic pulmonary fibrosis is a progressive fibrotic lung disease with limited therapeutic options and high lethality, related to alveolar type II epithelial (ATII) cell dysregulation, the abnormal repair of alveolar epithelial cells and activation of fibroblasts promote the development of pulmonary fibrosis. Fatty acid binding protein 1 (FABP1) was significantly downregulated in the fibrotic state by proteomics screening in our previous date, and the ATII cell dysregulation can be mediated by FABP1 via regulating fatty acid metabolism and intracellular transport. The aim of this study was to evaluate the role and potential mechanism of FABP1 in the development of pulmonary fibrosis. METHODS: Proteomics screening was used to detect changes of the protein profiles in two different types (induced by bleomycin and silica, respectively) of pulmonary fibrosis models. The localisation of FABP1 in mouse lung was detected by Immunofluorescence and immunohistochemistry. Experimental methods such as lung pathology, micro-CT, western blotting, small animal imaging in vivo, EdU, etc were used to verify the role of FABP1 in pulmonary fibrosis. RESULTS: The expression of FABP1 in the mouse lung was significantly reduced in the model of pulmonary fibrosis from our proteomic analysis and immunological methods, the double immunofluorescence staining showed that FABP1 was mainly localised in type II alveolar epithelial cells. Additionally, the expression of FABP1 was negatively correlated with the progression of pulmonary fibrosis. Further in vivo and in vitro experiments showed that overexpression of FABP1 alleviated pulmonary fibrosis by protecting alveolar epithelium from injury and promoting cell survival. CONCLUSION: Our findings provide a proof-of-principle that FABP1 may represent an effective treatment for pulmonary fibrosis by regulating alveolar epithelial regeneration, which may be associated with the fatty acid metabolism in ATII cells. BMJ Publishing Group 2023-11-08 /pmc/articles/PMC10632910/ /pubmed/37940355 http://dx.doi.org/10.1136/bmjresp-2022-001568 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Interstitial Lung Disease
Fu, Zhenli
Yin, Hang
Liu, Jiani
He, Ying
Song, Shengren
Peng, Xiaomin
Huang, Xihui
Lai, Yunxin
Li, Shuang
Luo, Qun
Su, Jin
Yang, Penghui
Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
title Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
title_full Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
title_fullStr Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
title_full_unstemmed Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
title_short Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
title_sort therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration
topic Interstitial Lung Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632910/
https://www.ncbi.nlm.nih.gov/pubmed/37940355
http://dx.doi.org/10.1136/bmjresp-2022-001568
work_keys_str_mv AT fuzhenli therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT yinhang therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT liujiani therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT heying therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT songshengren therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT pengxiaomin therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT huangxihui therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT laiyunxin therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT lishuang therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT luoqun therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT sujin therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration
AT yangpenghui therapeuticeffectsoffattyacidbindingprotein1inmicewithpulmonaryfibrosisbyregulatingalveolarepithelialregeneration